Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls

Rheumatology

Volumn 47, Issue 1, 2008, Pages 50-53

  Fitzgibbon, B M ^a   Fairhall, S L ^a   Kirk, I J ^a   Kalev Zylinska, M ^a   Pui, K ^b   Dalbeth, N ^a   Keelan, S ^a   Robinson, E ^a   During, M ^a   McQueen, F M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Auckland District Health Board ^*  (New Zealand)

Author keywords

Cognitive function; Functional MRI; Imaging; Neuropsychiatric manifestations; SLE

Indexed keywords

AZATHIOPRINE; CARBAMAZEPINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; LITHIUM; PREDNISOLONE; RITUXIMAB; VALPROIC ACID;

ADULT; ARTICLE; ATTENTION; BRAIN DYSFUNCTION; BRAIN SCINTISCANNING; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMISPHERE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MOTOR CORTEX; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE SCANNER; OXYGEN BLOOD LEVEL; PARIETAL LOBE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TASK PERFORMANCE; WORKING MEMORY;

ADULT; BRAIN MAPPING; FEMALE; FRONTAL LOBE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MEMORY DISORDERS; MEMORY, SHORT-TERM; OXYGEN; PARIETAL LOBE;

EID: 37349063197     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem287     Document Type: Article

References (17)

1. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979;8:212-21.
2. Loukkola J, Lalne M, Ainiala H et al. Cognitive Impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: A population-based neuropsychological study. J Clin Exp Neuropsychol 2003;25:145-51.
3. Diamond B, Volpe B. On the track of neuropsychiatric lupus. Arthritis Rheum 2003;48:2710-2.
4. Posse S, Binkofski F, Schneider F et al. A new approach to measure single-event related brain activity using real-time fMRI: Feasibility of sensory, motor, and higher cognitive tasks. Hum Brain Mapp 2001;12:25-41.
5. Rocca MA, Agosta F, Mzzapesa DM et al. An fRMI study of the motor system in patients with neuropsychiatric systemic lupus erythematosus. Neuroimage 2006;30:478-84.
6. Gevins A, Cutillo B. Spatiotemporal dynamics of component processes in human working memory. Electroencephalogr Clin Neurophysiol 1993;87:128-43.
7. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
8. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
9. Talairach J, Toumoux P, Musolino A, Missir O. Stereotaxic exploration in frontal epilepsy. Adv Neurol 1992;57:651-88.
10. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci 2002;3:243-9.
11. Lancaster JL, Woldorff MG, Parsons LM et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000;10:120-31.
12. Owen A, McMillan K, Laird A, Bullmore E. N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 2005;25;48-59.
13. Jonides J, Schumacher M, Smith EE et al. The role of the parietal cortex in verbal working memory. J Neurosci 1998;18:5026-34.
14. Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992;19:562-7.
15. Rocca MA, Falini A, Colombo B, Scotti G, Comi G, Filippi M. Adaptive-functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage. Ann Neurol 2002;51:330-9.
16. Weiner SM, Otte A, Schumacher M et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 2000;59;377-85.
17. Appenzeller S, Rondina JM, Li LM, Costallat LTL, Cendes F. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum 2005;52:2783-9.